CAMBRIDGE, Mass.--(BUSINESS WIRE)--Universal Diagnostics (Universal DX), a bioinformatics and multi-omics company on a mission to transform cancer into a curable disease, today announced the results ...
Financial support for this work was provided by the UK Biotechnology and Biological Sciences Research Council (BBSRC) Grant Number BB/1013245/1. The author has no other relevant affiliations or ...
Natera Reports Strong Advanced Adenoma Data from Prospective PROCEED-CRC Trial, Demonstrating 22.5% Sensitivity and 91.5% Specificity Findings underscore strength of Natera’s technology for early ...
Predictive cancer diagnostics company Rhythm Biosciences has achieved a major milestone with the peer-reviewed validation of ...
Saliva-based serology assays that measure antibodies against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antigens are important coronavirus disease 2019 (COVID-19) markers. Serology ...
Women living with and without HIV, age 30-65 years, were recruited in South Africa. Self-collected vaginal samples and clinician-collected cervical samples were tested with Xpert HPV, an assay that ...
Conclusions Symptoms, the SAC and the m-BESS have poor test-retest reliability. Symptoms have reasonable sensitivity and specificity for concussion but are subjective. The 3-word SAC and m-BESS are ...
The diagnostics advisory committee (section 8) considered evidence on tests used in secondary care to help identify people at high risk of ovarian cancer from several sources. Full details of all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results